Partnership combines Lunit's platform-agnostic AI pathology algorithms with CellCarta's global CDx development and laboratory execution to help biopharma teams de-risk assets and accelerate evidence ...

Deciding whether to administer chemotherapy after surgery is one of the most challenging questions in early-stage breast ...

Intended to assist biopharma developers of companion assays, the partnership follows one for clinical trial support the firms announced last year.

Craig Griffeth, 74, has always worried about cancer. “My aunts and uncles, almost all of them on both sides, died of cancer,” he said. “So, I figured that one day I’m going to get cancer, and I’ll ...

The funding will help transition the company’s AI lymphoma diagnostic into clinical use, with initial deployments in NHS ...

A research team from the Department of Pathology, School of Clinical Medicine, LKS Faculty of Medicine of the University of ...